chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Covid signs and symptoms as Cough, Headache, Fatigue which are all ongoing; strong Reaction to it / Reaction to Covid vaccine; Insomnia; Generalized Weakness; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid signs and symptoms as Cough, Headache, Fatigue which are all ongoing), IMMUNISATION REACTION (strong Reaction to it / Reaction to Covid vaccine), INSOMNIA (Insomnia) and ASTHENIA (Generalized Weakness) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Multiple sclerosis and Vertigo.    On 16-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid signs and symptoms as Cough, Headache, Fatigue which are all ongoing), IMMUNISATION REACTION (strong Reaction to it / Reaction to Covid vaccine), INSOMNIA (Insomnia) and ASTHENIA (Generalized Weakness). At the time of the report, COVID-19 (Covid signs and symptoms as Cough, Headache, Fatigue which are all ongoing), IMMUNISATION REACTION (strong Reaction to it / Reaction to Covid vaccine), INSOMNIA (Insomnia) and ASTHENIA (Generalized Weakness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  The patient had a strong reaction to covid vaccine which delayed her getting her Ocrevus Infusion. She described the symptoms of the reaction as being worse than having Multiple Sclerosis. The HCP wanted her to go ahead and get another covid vaccine, but she was unsure if she would get another one or not and would discuss it when she sees the Doctor again. The patient also had chills, but they have resolved. Patient stated that she felt she just needed a good night's sleep and would feel some better.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jan-2023: Follow up received contains no new information.
On 1-6-03 received Anthrax #1. Couple of hrs later boarded plane to deploy and became nauseated. One week later noted problems with balance, emesis x5-6, and headache. Denied diarrhea, fever, sore throat or other symptoms. Stated no one else in unit became sick. Reported adequate fluid intake. Symptoms lasted approx one day. Felt fine for remainder of tour.   Returned to States and received anthrax #2 on 4-25-03. One hour later became nauseated with emesis 4-5 times. One wk later again reported problems with balance, nausea with emesis, and night sweats the night before. Reports no visual problems and is unable to associate symptoms with any activity. Symptoms start to ease throughout the day and by the next day he is back to normal. Symptoms reoccur approx 2-3 times every month since the anthrax vaccine. Last episode was on Nov 27/03. States symptoms are always the same. Pt sought medical attention once for these symptoms and was given I.V. fluids. Stated he had labs drawn, but no other diagnostic work up.   Also states that he has intermittent headaches, and joint pain from waist down. Had a previous fracture of rt ankle and now reports occasional swelling of that ankle. Pain is described as dull and achy. Is able to fit into boots and shoes. For the pain he has tried various medication including Ultracet, Bextra and Percocet. Has taken 4 Percocet without relief.  Within last 2 months has noted an area in center of chest just above umbilicus as being dry and slightly red. Denies any itching and change in lotions, soaps and detergents. Rash does not bother him and is nowhere else on body.
I received the first shot of GARDASIL on 06/07/13. I became faint, dizzy, nauseous, my heart rate went up, and I felt extremely hot right after getting the shot. I had to stay in the emergency room for most of the night due to how bad my symptoms were. The day after receiving the shot I am still dizzy and feel off balance. I would have NEVER gotten this shot if I knew that was going to happen, and I don't know how long I will have this dizziness.
Leg became hot & enlarged in PM w/immun; MD dx pt w/cellulitis to inject site; MD started pt on ATB;
Child became very pale, lightheaded and felt like she was going to faint. Child was also slightly diaphoretic. Had child lay down and gave water.
Second shot was received on 4/30/2021. My very regular and predictable period was due on 5/7/2021. The shot delayed my period by 1 week and it started on 5/14/2021. 5 pregnancy tests were taken in that week and all were negative. I track and chart my cycle closely because of my endometriosis so I'm able to plan my life around my debilitating symptoms. I did have the typical feeling really bad and stuck in bed the day after the vaccine. However, the day after that, 2 days after the shot, my typically debilitating premenstrual symptoms were stopped and I felt great, better than I have in a long time. Until the day before my period started on 5/13/2021 when I got a migraine (not typical for me) The migraine continued for 2 days. I was bed bound for those 2 days between the period pain and the migraine. The 3rd day and the last day of the period I felt much better and was able to resume regular activities. My period typically last for 5 days and is usually very heavy in the first 2-3 days. This period only lasted 3 days and was much lighter flow than is normal for me.
mouth blister; rash on right arm started on day one; This spontaneous case was reported by a consumer and describes the occurrence of ORAL MUCOSAL BLISTERING (mouth blister) and VACCINATION SITE RASH (rash on right arm started on day one) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concomitant products included IRON for Iron supplementation, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), BUDESONIDE, CROMOGLICATE SODIUM (NASALCROM), ASPIRIN [ACETYLSALICYLIC ACID], IPRATROPIUM, ALBUTEROL [SALBUTAMOL], VITAMIN D NOS, FOLIC ACID, FAMOTIDINE (PEPCID [FAMOTIDINE]), EPINEPHRINE (EPIPEN) and OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE RASH (rash on right arm started on day one). On 12-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ORAL MUCOSAL BLISTERING (mouth blister). The patient was treated with PREDNISOLONE at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ORAL MUCOSAL BLISTERING (mouth blister) and VACCINATION SITE RASH (rash on right arm started on day one) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Full blood count: pending (Inconclusive) pending. On an unknown date, Heart rate: elevated (High) Elevated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       In concomitant medications nasal spray was also included.
This spontaneous report as received from a Registered Nurse refers to an unknown number of patients. It was reported that on unspecified dates, an unknown number of patients were vaccinated with RECOMBIVAX HB (lot#, expiration date, dose, route of administration, thimerosal status and indication were not provided) that had been improperly stored. No adverse effects were reported. No further information was provided. Additional information has been requested.
I started having signs of atrial fibrillation. I could feel an irregular heartbeat so I started monitoring it at home by my blood pressure machine. Then I went to the hospital ER on 4-27-2021 and they confirmed my atrial fibrillation. It subsided on it's own in the ER. In the next 3-4 days, I probably had 4 more episodes but then it eventually went away.
Ishemic Stroke - Right Side paralisys  Disabled  Unable to work Unable to drive Speech, Walking and Right dominant arm and hand are disabled
missed 2nd dose,its almost 9 weeks and 2 days passed after the 1st dose .; Recived moderna vaccine at 16 years of age; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed 2nd dose,its almost 9 weeks and 2 days passed after the 1st dose .) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Recived moderna vaccine at 16 years of age) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed 2nd dose,its almost 9 weeks and 2 days passed after the 1st dose .) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Recived moderna vaccine at 16 years of age). On 22-Jan-2021, PRODUCT DOSE OMISSION ISSUE (missed 2nd dose,its almost 9 weeks and 2 days passed after the 1st dose .) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Recived moderna vaccine at 16 years of age) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Headache, Myalgia, NauseaVomiting, Injection site pain; chills; stiff neck; fatigue Narrative:
20 mm / 20 mm - red knot at varicella inj point. (Hive) Treatment: no Rx, cool compress.
This spontaneous report was received from a nurse referring to an unspecified number of patients of unknown genders and ages. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patients were vaccinated with improperly stored dose of PNEUMOVAX23 with a Lot # reported as L029306 with an expiration date of 26-MAR-2017 and with Lot # reported as M0275552 with an expiration date of  04-FEB-2018 (strength, dose and route of administration were not reported) for prophylaxis, however no adverse effects reported. It was reported that from 23-DEC-2016 to 31-DEC-2016, the vaccine was exposed to a temperature of 32 to 36 Fahrenheit degrees range (0 to 1 centigrade degrees) for a time frame of 177.5 hours (for 6 cycles); from 03-JAN-2017 to 31-JAN-2017, the vaccine was exposed to the same temperature for a time frame of 464.5 hours (for 21 cycles); from 02-FEB-2017 to 28-FEB-2017, the time frame was 409.5 hours (for 16 cycles) and from 01-MAR-2017 to 15-MAR-2017, the time frame was 61 hours (for 6 cycles). The temperature excursion was recorded by a data logger and no previous excursions were reported for the vaccines. There was no product quality complaint involved. This is one of the several reports received from the same reporter.  Additional information has been requested.; Sender's Comments:  US-009507513-1704USA004439: US-009507513-1703USA010028: US-009507513-1704USA004440: US-009507513-1704USA004437:
Dizziness, weakness and fatigue.  Had an Echocardiogram and stress test and all was good.
This is a spontaneous report from a non-contactable Pharmacy student reporting on behalf of a Pharmacist. A male patient of an unspecified age and ethnicity received PREVNAR 13, via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced reaction at the site that immediately swelled up and it became hard on an unspecified date with outcome of unknown. The reported stated that the patient is planned to have another vaccine in 3 months and I wanted to know if whether he should get that vaccine or not. No follow-up attempts are possible. No further information is expected.
I had 104 fever which ran for 2- 4 days, I lost my sense of taste and smell, bad headaches and cough. I felt like I had COVID-19 again. They put me back on inhaler. I still don't have my taste and smell back after receiving my vaccine
A non-serious spontaneous report of Flu-like symptoms has been received from a consumer/mother concerning her 11-year-old daughter, subsequent to FLUMIST. The patient's past medical history and concomitant medications were not reported. About two months ago in approximately September 2009, the patient received FLUMIST. The same night after the vaccine was administered, the patient experienced a fever and other mild flu-like symptoms. The event resolved within 24 hours of onset.
Swelling of the left wrist; Swelling of both hands; swelling a little bit from the back side of the neck on the left side; little bit of rashes on his right hand near the elbow/itchy and gradually spreading all over the body which then becomes more itchy; Rashes on palms/rashes on both legs/rashes on thigh area.; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Swelling of the left wrist), PERIPHERAL SWELLING (Swelling of both hands), SWELLING (swelling a little bit from the back side of the neck on the left side), RASH PRURITIC (little bit of rashes on his right hand near the elbow/itchy and gradually spreading all over the body which then becomes more itchy) and RASH (Rashes on palms/rashes on both legs/rashes on thigh area.) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced JOINT SWELLING (Swelling of the left wrist), PERIPHERAL SWELLING (Swelling of both hands), SWELLING (swelling a little bit from the back side of the neck on the left side), RASH PRURITIC (little bit of rashes on his right hand near the elbow/itchy and gradually spreading all over the body which then becomes more itchy) and RASH (Rashes on palms/rashes on both legs/rashes on thigh area.). At the time of the report, JOINT SWELLING (Swelling of the left wrist), PERIPHERAL SWELLING (Swelling of both hands), SWELLING (swelling a little bit from the back side of the neck on the left side), RASH PRURITIC (little bit of rashes on his right hand near the elbow/itchy and gradually spreading all over the body which then becomes more itchy) and RASH (Rashes on palms/rashes on both legs/rashes on thigh area.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication included Methylprednisolone 4mg tablet (he is not yet taking this)  No concomitant medication was reported.
Constant left shoulder pain with radiation down arm.  Unable to raise arm over shoulder.  Stinging sensation in hand.
Pain in right shoulder (R) opposite arm; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain in right shoulder (R) opposite arm) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced ARTHRALGIA (Pain in right shoulder (R) opposite arm). At the time of the report, ARTHRALGIA (Pain in right shoulder (R) opposite arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
soreness in the right knee; This is a spontaneous report from a contactable consumer (patient) received via COVAES. A 63-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EN5318 and Expiration date: not reported) via an unspecified route of administration, administered on the left arm on 28Jan2021 11:00 (at the age of 63 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history was reported as none. The patient has no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. Concomitant medications included simvastatin, ascophyllum nodosum;ascorbic acid;ascorbyl palmitate;bacopa monnieri leaf;betacarotene;biotin;boron citrate;calcium ascorbate;calcium citrate;calcium pantothenate;calcium succinate;choline bitartrate;chromium nicotinate;colecalciferol;copper citrate;copper glycinate;cyanocobalamin;deanol bitartrate;docosahexaenoic acid;electrolytes nos;folic acid;gamma-aminobutyric acid;huperzia serrata;inositol;inositol nicotinate;iron pentacarbonyl;levoglutamide;magnesium citrate;magnesium malate;magnesium taurate;manganese citrate;molybdenum amino acid chelate;n-acetyltyrosin;nicotinamide;nutrients nos;phosphatidyl serine;potassium ascorbate;potassium aspartate;potassium citrate;pyridoxal phosphate;pyridoxine oxoglurate;riboflavin;selenomethionine;sodium ascorbate;thiamine mononitrate;tocopheryl acid succinate;vaccinium myrtillus fruit;vanadyl sulfate;vinpocetine;vitis vinifera;zinc ascorbate;zinc citrate (FOCUSFACTOR), and ascorbic acid, calcium, minerals nos, retinol, tocopheryl acetate, vitamin b nos, vitamins nos, zinc (CENTRUM SILVER) taken for unspecified indications. On 30Jan2021, about 2 days following the first shot, the patient experienced soreness in the right knee that progressively got to the point that the patient couldn't apply pressure on his right leg. On 18Feb2021, the patient saw an orthopedic surgeon for an assessment and they identified some water on the knee; result not reported. The patient was given a cortisone shot. The outcome of the reported event was recovering.  No follow-up attempts are needed. No further information is expected.
Within 2 hours of receiving Pfizer shot, I got heart palpitations, shortness of breath, inflammation, joint pain and swelling, back aches.  Shortness of breath continues and has impacted normal life and normal daily activity.  Walking up the stairs causes shortness of breath, doing light chores around the house causes shortness of breath like vacuuming, cleaning the bathroom, carrying a load of laundry causes shortness of breath, etc.
Extreme fatigue, chills, loss of appetite. I just tried to sleep the whole day after the vaccine and it seems to have gotten a little better two days after the vaccine.
rash all over my face; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In May 2022, the patient received the 1st dose of Shingles vaccine. On an unknown date, 1 week after receiving Shingles vaccine, the patient experienced rash. On an unknown date, the outcome of the rash was not recovered/not resolved.   It was unknown if the reporter considered the rash to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 13-JUN-2022 Reporter's Comments: The case was self-reported by the patient via interactive digital media. The patient received dose of Shingles vaccine about three weeks ago before the day of reporting and one week later patient broke out with a rash all over face.  The patient reported that It was going into the second week and was no better.  The patient asked that could you have a shingles type reaction to the vaccine. Additional Supportive Information: The follow-up would not possible, as no contact details were available.
This is a spontaneous report from a contactable consumer or other non HCP (the patient). A 71-years-old male patient received PREVNAR 13, intramuscular on 01Feb2019 at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced chills on 03Feb2019 with outcome of recovered, fever on 03Feb2019 with outcome of recovered, no energy on 03Feb2019 with outcome of not recovered. All the reported events were considered non serious. The patient is having horrible adverse reactions and it has been 8 days. The patient stated that Pfizer puts out a product that almost kills people. He clarified that two days after receiving the product he experienced chills, fever, and was with no energy. The chills started around 11 PM Sunday night. The fever also started on Sunday. Both the fever and chill took about 3 or 4 days to recover completely. He is still feeling like he has no energy. The information on the batch number has been requested.
One week after the first dose I experienced angioedema and lip swelling with blisters that lasted 3 weeks and didn?t resolve until March 4th. On March 6th I received the second dose completely healed with no symptoms and two days later I experienced tingling itching blisters and swelling that is currently still ongoing as of 3/23/2021.
31OCT96 rt upper arm became puffy w/red patches & red lines going to lymph under arm;1NOV redness went up arm to base of neck, warm to touch & pains;2NOV sl red above elbow & feels warm;took med & put cold & warm on arm;
Patient reported her arm was very red after the injection and hot to the touch two days after her injection.  It had continued to get worse so she called.  She was not in pain but concerned that she had flu shots previously and never had a problem.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10Apr2021 as dose 1, single (Lot number: EW0161), in right arm, on 01May2021 as dose 2, single (Lot number: EW0164), in right arm, on 23Nov2021 as dose 3 (booster), single (Lot number: FH8027), in right arm and on 09Apr2022 at 13:00 as dose 4 (booster), single (Lot number: FK9895) at the age of 54 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "thyroid removed" (not ongoing). Concomitant medication(s) included: LEVOTHYROXINE, start date: 01Jan2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (13Dec2022) Negative, notes: 4 days after first negative test result; (15Dec2022) Negative, notes: Tested negative 6 and 7 days after starting paxlovid; (16Dec2022) Negative, notes: Tested negative 6 and 7 days after starting paxlovid. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient had no known allergies. Patient had levothyroxine in 2 weeks. Anti-viral treatment with Paxlovid from 09Dec2022 to 14Dec2022.   No follow up attempts required. No further information expected.